original image from www.freefoto.com cvEpi - Collaboration & Resources for the Cardiovascular Epidemiology Community
About CV EPICollaborationTrainee ResearchTraining and CareerConferences & EventsEmployment
Trainee Research
  Influenza Vaccination and The Risk of All-Cause and Coronary Heart Disease Mortality in Older Adults: The Cardiovascular Health Study

 


EA Sidman, NL Smith, LA Jackson, University of Washington,
GL. Burke, Wake Forest University, PHM Chaves, Johns Hopkins University, TG Evans, University of California, Davis, AB Newman, University of Pittsburgh, DS Siscovick, University of Washington


Excess mortality occurs during influenza outbreaks, and cardiovascular diseases are a major contributor to the excess mortality not directly attributed to influenza or pneumonia. Inflammatory responses to infections may trigger cardiovascular events or promote atherosclerosis. We examined whether influenza vaccination late in life was associated with reductions in all-cause, coronary heart disease (CHD), and non-CHD mortality in the Cardiovascular Health Study, a longitudinal, population-based, study of 5,888 adults aged =65 years. Participants reported their influenza vaccination status at baseline and annually during follow-up. Data from 1993-1997 were used. Fatal events occurring throughout follow-up and during periods in which influenza was and was not expected to be circulating were assessed. Cox regressions were carried out with influenza vaccination status modeled first as a time-dependent variable, and then as a non-time-dependent variable based on participants' joint 1992/1993 vaccination status. Using the time-dependent method, vaccine recipients were approximately 15% less likely to die than were non-recipients after controlling for demographic and health status differences (all-cause: HR = 0.84, 95% CI = 0.73 - 0.95; CHD: 0.81 [0.63 - 1.05]; non-CHD: 0.85 [0.73 - 0.99]). No associations were observed between time-dependent vaccination status and all-cause or non-CHD mortality during influenza seasons. In non-influenza periods, vaccine recipients were at lower risk of all-cause and non-CHD mortality relative to non-recipients (all-cause: 0.72 [0.61 - 0.86]; non-CHD: 0.68 [0.55 - 0.84]). Lower risks of CHD death were observed during influenza and non-influenza periods but were non-significant. Non-time-dependent analyses comparing participants vaccinated in both 1992 and 1993 with those unvaccinated in both years were generally similar, except that stronger inverse associations were observed between vaccination status and CHD mortality (influenza seasons: 0.52 [0.31 - 0.86]; non-influenza periods: 0.67 [0.43 - 1.05]; combined: 0.60 [0.43 - 0.84]). Lower risks of mortality associated with influenza vaccination late in life may reflect an effect of vaccination on acute or chronic disease risk, or selection bias if vaccination is a marker for other healthy behaviors.

View Slides

     
Site development funded by the NHLBI
CVD Epidemiology Group - UNC Chapel Hill
Copyright 2001 - Site use statement